Categories
Tags
recipientpatient hemovigilance - noninfectious adverse events
leukocytesincludes experimental transplantationimmunotherapy
recipientpatient hemovigilance - transfusion transmitted infec
leukocytes includes experimental transplantationimmunotherapy
cell biology immunology and biochemistry basic and preclinical
immunohematology and genetic testing red cells leukocytes and
Transfusion Medicine Clinical Practices and Trauma and Massive T
RecipientPatient Hemovigilance - Transfusion Transmitted Infect
recipientpatient hemovigilance-txn trans infectious diseases
Quality Management and Transfusion Medicine Clinical Practices
trainingeducation methods information technology it aka info
transfusion service platelets disorders trauma and massive tr
Recipient/Patient Hemovigilance – Noninfectious Adverse Events (Transfusion Reactions)
DateOctober 23, 2024Credits1 General Continuing Education (GEN) | 1 Florida Lab Personnel (FLP) | 1 California Nurse (CN) | 1 California Lab Personnel (CLP)“First do no harm” has been the central dogma of practice of medicine since antiquity and continues to be the guiding principle today. Efforts have been made at local, national and international levels to ensure that patient safety is at the forefront of all aspects of clinical care…Moderator
Speakers
$30Standard PriceMembers save $5
DateOctober 23, 2024Credits1.5 General Continuing Education (GEN) | 1.5 Florida Lab Personnel (FLP) | 1.5 California Nurse (CN) | 1.5 California Lab Personnel (CLP) | 1.5 Physician (PHY)Transfusion Safety Officers (TSO) are are being increasingly recognized as an important component of blood transfusion safety…Moderator
Speakers
Asawari Bapat, MD, PGDHHM, CABP(H), DABRM, FABRM.Global Regenerative Medicine Consultant
Nour AlMozain, MDAssociate Consultant, Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital & Research Center$30Standard PriceMembers save $5
